Annual Net Income
-$26.94 M
+$14.08 M+34.32%
December 31, 2023
Summary
- As of March 6, 2025, CASI annual net profit is -$26.94 million, with the most recent change of +$14.08 million (+34.32%) on December 31, 2023.
- During the last 3 years, CASI annual net income has risen by +$21.35 million (+44.21%).
- CASI annual net income is now -490.94% below its all-time high of -$4.56 million, reached on December 31, 2011.
Performance
CASI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$8.39 M
-$1.43 M-20.53%
September 1, 2024
Summary
- As of March 6, 2025, CASI quarterly net profit is -$8.39 million, with the most recent change of -$1.43 million (-20.53%) on September 1, 2024.
- Over the past year, CASI quarterly net income has dropped by -$2.34 million (-38.65%).
- CASI quarterly net income is now -236.17% below its all-time high of $6.17 million, reached on September 30, 2001.
Performance
CASI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$30.94 M
-$3.76 M-13.83%
September 1, 2024
Summary
- As of March 6, 2025, CASI TTM net profit is -$30.94 million, with the most recent change of -$3.76 million (-13.83%) on September 1, 2024.
- Over the past year, CASI TTM net income has dropped by -$4.00 million (-14.87%).
- CASI TTM net income is now -1720.18% below its all-time high of -$1.70 million, reached on March 31, 1996.
Performance
CASI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CASI Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +34.3% | -38.6% | -14.9% |
3 y3 years | +44.2% | -38.6% | -14.9% |
5 y5 years | +1.9% | -38.6% | -14.9% |
CASI Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +34.3% | -81.1% | +57.0% | -14.9% | +24.6% |
5 y | 5-year | at high | +44.2% | -81.1% | +57.0% | -14.9% | +42.4% |
alltime | all time | -490.9% | +46.0% | -236.2% | +75.8% | -1720.2% | +49.7% |
CASI Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$8.39 M(+20.5%) | -$30.94 M(+13.8%) |
Jun 2024 | - | -$6.96 M(-26.9%) | -$27.18 M(-10.7%) |
Mar 2024 | - | -$9.53 M(+57.4%) | -$30.46 M(+13.1%) |
Dec 2023 | -$26.94 M(-34.3%) | -$6.05 M(+30.6%) | -$26.94 M(-33.4%) |
Sep 2023 | - | -$4.63 M(-54.7%) | -$40.42 M(-1.4%) |
Jun 2023 | - | -$10.24 M(+70.4%) | -$40.99 M(+6.7%) |
Mar 2023 | - | -$6.01 M(-69.2%) | -$38.43 M(-6.3%) |
Dec 2022 | -$41.01 M(+11.9%) | -$19.54 M(+275.6%) | -$41.01 M(+51.5%) |
Sep 2022 | - | -$5.20 M(-32.3%) | -$27.08 M(-15.6%) |
Jun 2022 | - | -$7.68 M(-10.7%) | -$32.10 M(+2.3%) |
Mar 2022 | - | -$8.60 M(+53.5%) | -$31.37 M(-14.4%) |
Dec 2021 | -$36.65 M(-24.1%) | -$5.60 M(-45.2%) | -$36.65 M(-19.0%) |
Sep 2021 | - | -$10.22 M(+47.2%) | -$45.25 M(-12.9%) |
Jun 2021 | - | -$6.95 M(-50.0%) | -$51.98 M(-3.3%) |
Mar 2021 | - | -$13.88 M(-2.2%) | -$53.73 M(+11.3%) |
Dec 2020 | -$48.29 M(+4.9%) | -$14.20 M(-16.2%) | -$48.29 M(+3.7%) |
Sep 2020 | - | -$16.95 M(+95.0%) | -$46.58 M(+17.9%) |
Jun 2020 | - | -$8.69 M(+3.0%) | -$39.52 M(-14.6%) |
Mar 2020 | - | -$8.44 M(-32.4%) | -$46.30 M(+0.6%) |
Dec 2019 | -$46.03 M(+67.6%) | -$12.49 M(+26.3%) | -$46.03 M(+7.5%) |
Sep 2019 | - | -$9.89 M(-36.1%) | -$42.80 M(+2.7%) |
Jun 2019 | - | -$15.47 M(+89.2%) | -$41.67 M(+30.0%) |
Mar 2019 | - | -$8.18 M(-11.7%) | -$32.06 M(+16.7%) |
Dec 2018 | -$27.47 M(+155.1%) | -$9.26 M(+5.8%) | -$27.47 M(+18.1%) |
Sep 2018 | - | -$8.76 M(+49.4%) | -$23.25 M(+44.3%) |
Jun 2018 | - | -$5.86 M(+63.2%) | -$16.11 M(+27.3%) |
Mar 2018 | - | -$3.59 M(-28.9%) | -$12.66 M(+17.6%) |
Dec 2017 | -$10.77 M(+13.9%) | -$5.05 M(+212.9%) | -$10.77 M(+28.3%) |
Sep 2017 | - | -$1.61 M(-33.0%) | -$8.40 M(-0.9%) |
Jun 2017 | - | -$2.41 M(+41.7%) | -$8.48 M(-9.4%) |
Mar 2017 | - | -$1.70 M(-36.4%) | -$9.36 M(-1.0%) |
Dec 2016 | -$9.45 M(+31.2%) | -$2.67 M(+57.9%) | -$9.45 M(+11.4%) |
Sep 2016 | - | -$1.69 M(-48.6%) | -$8.48 M(+1.1%) |
Jun 2016 | - | -$3.29 M(+83.5%) | -$8.39 M(+16.6%) |
Mar 2016 | - | -$1.79 M(+5.4%) | -$7.20 M(-0.1%) |
Dec 2015 | -$7.21 M(-72.5%) | -$1.70 M(+6.1%) | -$7.21 M(+1.5%) |
Sep 2015 | - | -$1.60 M(-23.4%) | -$7.10 M(-73.7%) |
Jun 2015 | - | -$2.10 M(+16.2%) | -$27.03 M(+1.8%) |
Mar 2015 | - | -$1.80 M(+12.9%) | -$26.55 M(+1.3%) |
Dec 2014 | -$26.20 M(+356.6%) | -$1.60 M(-92.6%) | -$26.20 M(+1.1%) |
Sep 2014 | - | -$21.54 M(+1232.6%) | -$25.91 M(+345.4%) |
Jun 2014 | - | -$1.62 M(+11.4%) | -$5.82 M(-3.9%) |
Mar 2014 | - | -$1.45 M(+10.9%) | -$6.05 M(+5.5%) |
Dec 2013 | -$5.74 M(-60.5%) | -$1.31 M(-9.3%) | -$5.74 M(+19.8%) |
Sep 2013 | - | -$1.44 M(-22.1%) | -$4.79 M(+5.6%) |
Jun 2013 | - | -$1.85 M(+63.0%) | -$4.54 M(-65.5%) |
Mar 2013 | - | -$1.14 M(+215.2%) | -$13.15 M(-9.6%) |
Dec 2012 | -$14.55 M(+219.1%) | -$360.40 K(-69.7%) | -$14.55 M(+10.4%) |
Sep 2012 | - | -$1.19 M(-88.6%) | -$13.18 M(-0.9%) |
Jun 2012 | - | -$10.46 M(+312.9%) | -$13.30 M(+195.8%) |
Mar 2012 | - | -$2.53 M(-352.3%) | -$4.50 M(-1.4%) |
Dec 2011 | -$4.56 M(-43.7%) | $1.00 M(-176.8%) | -$4.56 M(+1.3%) |
Sep 2011 | - | -$1.31 M(-21.1%) | -$4.50 M(-14.9%) |
Jun 2011 | - | -$1.66 M(-36.1%) | -$5.29 M(-38.3%) |
Mar 2011 | - | -$2.60 M(-343.8%) | -$8.57 M(+5.8%) |
Dec 2010 | -$8.10 M | $1.06 M(-150.8%) | -$8.10 M(-25.7%) |
Sep 2010 | - | -$2.10 M(-57.6%) | -$10.90 M(+25.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2010 | - | -$4.94 M(+132.6%) | -$8.72 M(+27.7%) |
Mar 2010 | - | -$2.13 M(+22.7%) | -$6.83 M(-16.9%) |
Dec 2009 | -$8.22 M(-65.6%) | -$1.73 M(-2141.6%) | -$8.22 M(-9.0%) |
Sep 2009 | - | $84.90 K(-102.8%) | -$9.03 M(-27.8%) |
Jun 2009 | - | -$3.05 M(-13.2%) | -$12.51 M(-34.3%) |
Mar 2009 | - | -$3.52 M(+38.0%) | -$19.03 M(-20.2%) |
Dec 2008 | -$23.86 M(+6.5%) | -$2.55 M(-25.0%) | -$23.86 M(-4.9%) |
Sep 2008 | - | -$3.40 M(-64.5%) | -$25.08 M(+1.5%) |
Jun 2008 | - | -$9.57 M(+14.7%) | -$24.72 M(+7.1%) |
Mar 2008 | - | -$8.35 M(+121.5%) | -$23.08 M(+3.0%) |
Dec 2007 | -$22.41 M(-55.1%) | -$3.77 M(+24.1%) | -$22.41 M(-7.7%) |
Sep 2007 | - | -$3.04 M(-61.7%) | -$24.27 M(-2.0%) |
Jun 2007 | - | -$7.93 M(+3.4%) | -$24.76 M(+8.4%) |
Mar 2007 | - | -$7.67 M(+36.4%) | -$22.85 M(-54.2%) |
Dec 2006 | -$49.89 M(+205.8%) | -$5.63 M(+59.6%) | -$49.89 M(+7.4%) |
Sep 2006 | - | -$3.52 M(-41.5%) | -$46.44 M(-1.8%) |
Jun 2006 | - | -$6.03 M(-82.6%) | -$47.29 M(+3.8%) |
Mar 2006 | - | -$34.71 M(+1494.6%) | -$45.57 M(+179.3%) |
Dec 2005 | -$16.31 M(+29.2%) | -$2.18 M(-50.3%) | -$16.31 M(+13.3%) |
Sep 2005 | - | -$4.38 M(+1.9%) | -$14.40 M(+9.4%) |
Jun 2005 | - | -$4.30 M(-21.2%) | -$13.16 M(+0.4%) |
Mar 2005 | - | -$5.46 M(+1998.7%) | -$13.11 M(+3.9%) |
Dec 2004 | -$12.62 M(-35.3%) | -$260.00 K(-91.7%) | -$12.62 M(-31.1%) |
Sep 2004 | - | -$3.15 M(-25.9%) | -$18.31 M(-7.3%) |
Jun 2004 | - | -$4.25 M(-14.5%) | -$19.76 M(-4.9%) |
Mar 2004 | - | -$4.97 M(-16.5%) | -$20.77 M(+6.5%) |
Dec 2003 | -$19.49 M(-50.0%) | -$5.95 M(+29.4%) | -$19.49 M(+29.5%) |
Sep 2003 | - | -$4.60 M(-12.6%) | -$15.05 M(-32.2%) |
Jun 2003 | - | -$5.26 M(+42.5%) | -$22.21 M(-21.3%) |
Mar 2003 | - | -$3.69 M(+145.2%) | -$28.20 M(-27.7%) |
Dec 2002 | -$39.02 M(-9.9%) | -$1.50 M(-87.2%) | -$39.02 M(-36.6%) |
Sep 2002 | - | -$11.75 M(+4.4%) | -$61.52 M(+41.1%) |
Jun 2002 | - | -$11.25 M(-22.5%) | -$43.60 M(-7.7%) |
Mar 2002 | - | -$14.51 M(-39.5%) | -$47.23 M(+9.1%) |
Dec 2001 | -$43.31 M(-11.2%) | -$24.00 M(-489.3%) | -$43.31 M(+31.1%) |
Sep 2001 | - | $6.17 M(-141.4%) | -$33.04 M(-34.6%) |
Jun 2001 | - | -$14.88 M(+40.4%) | -$50.49 M(+3.6%) |
Mar 2001 | - | -$10.59 M(-22.9%) | -$48.75 M(-0.1%) |
Dec 2000 | -$48.79 M(+32.2%) | -$13.74 M(+21.8%) | -$48.79 M(-2.1%) |
Sep 2000 | - | -$11.28 M(-14.1%) | -$49.86 M(+9.6%) |
Jun 2000 | - | -$13.13 M(+23.4%) | -$45.48 M(+12.7%) |
Mar 2000 | - | -$10.64 M(-28.1%) | -$40.35 M(+9.5%) |
Dec 1999 | -$36.90 M(+173.3%) | -$14.80 M(+114.5%) | -$36.86 M(+38.3%) |
Sep 1999 | - | -$6.90 M(-13.8%) | -$26.66 M(+12.2%) |
Jun 1999 | - | -$8.01 M(+12.0%) | -$23.76 M(+35.4%) |
Mar 1999 | - | -$7.15 M(+55.4%) | -$17.55 M(+30.0%) |
Dec 1998 | -$13.50 M(+107.7%) | -$4.60 M(+15.0%) | -$13.50 M(+22.7%) |
Sep 1998 | - | -$4.00 M(+122.2%) | -$11.00 M(+25.0%) |
Jun 1998 | - | -$1.80 M(-41.9%) | -$8.80 M(+7.3%) |
Mar 1998 | - | -$3.10 M(+47.6%) | -$8.20 M(+26.2%) |
Dec 1997 | -$6.50 M(+35.4%) | -$2.10 M(+16.7%) | -$6.50 M(+14.0%) |
Sep 1997 | - | -$1.80 M(+50.0%) | -$5.70 M(+7.5%) |
Jun 1997 | - | -$1.20 M(-14.3%) | -$5.30 M(+15.2%) |
Mar 1997 | - | -$1.40 M(+7.7%) | -$4.60 M(-6.1%) |
Dec 1996 | -$4.80 M | -$1.30 M(-7.1%) | -$4.90 M(+36.1%) |
Sep 1996 | - | -$1.40 M(+180.0%) | -$3.60 M(+63.6%) |
Jun 1996 | - | -$500.00 K(-70.6%) | -$2.20 M(+29.4%) |
Mar 1996 | - | -$1.70 M | -$1.70 M |
FAQ
- What is CASI Pharmaceuticals annual net profit?
- What is the all time high annual net income for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual net income year-on-year change?
- What is CASI Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly net income year-on-year change?
- What is CASI Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals TTM net income year-on-year change?
What is CASI Pharmaceuticals annual net profit?
The current annual net income of CASI is -$26.94 M
What is the all time high annual net income for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual net profit is -$4.56 M
What is CASI Pharmaceuticals annual net income year-on-year change?
Over the past year, CASI annual net profit has changed by +$14.08 M (+34.32%)
What is CASI Pharmaceuticals quarterly net profit?
The current quarterly net income of CASI is -$8.39 M
What is the all time high quarterly net income for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly net profit is $6.17 M
What is CASI Pharmaceuticals quarterly net income year-on-year change?
Over the past year, CASI quarterly net profit has changed by -$2.34 M (-38.65%)
What is CASI Pharmaceuticals TTM net profit?
The current TTM net income of CASI is -$30.94 M
What is the all time high TTM net income for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high TTM net profit is -$1.70 M
What is CASI Pharmaceuticals TTM net income year-on-year change?
Over the past year, CASI TTM net profit has changed by -$4.00 M (-14.87%)